OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!

XClose

2011 Ann Schreiber Grant Recipient – Gregory Motz

Gregory Motz, PhD
University of Pennsylvania
Stimulating Immune Cells to Fight Ovarian Cancer

Project Summary

Cancer vaccines, or treatments that enhance a patient’s immune system to fight tumor cells, hold great promise as a therapy for ovarian cancer. However, existing immunotherapies for ovarian cancer have been limited, highlighting the need for new approaches to achieve immunotherapy’s full potential for ovarian cancer. In Dr. Motz’s research, he aims to create special T-cells, or immune cells, that will be very effective in killing tumor cells. He will be working with a mouse model of ovarian cancer, but his findings could someday be applied to patient care.

Bio

Dr. Gregory Motz is a postdoctoral fellow in the laboratory of Dr. George Coukos at the University of Pennsylvania. He completed his doctoral thesis on the immune response in chronic obstructive pulmonary disease at the University of Cincinnati. He has since redirected his research interests to focus on the immune response in ovarian cancer. He is currently interested in cancer vaccines, barriers to anti-tumor immunity, and angiogenesis in tumor immunology.

This grant is supported in part by a generous donation from Teal There’s a Cure.